Biogen (BIIB)

Operating Expenses

$5.46B

TTM · Period ending: · USD

BIIB logo

BIIB Operating Expenses

Latest reported$5.46B
BIIB Operating Expenses ($10.60M → $5.46B)
High-resolution chart · PNG

BIIB operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biogen Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
5,036,100,000
4,875,200,000
5,204,900,000
5,006,000,000
6,080,600,000
7,046,400,000
5,379,900,000
5,748,000,000
5,298,100,000
4,863,900,000
4,632,400,000
4,559,900,000
3,559,000,000
3,111,780,000
2,857,163,000
3,067,272,000
2,699,817,000
2,481,907,000
2,056,653,000
1,968,646,000
1,103,965,000
998,084,000
771,064,000
188,889,000
545,604,000
472,111,000
367,179,000
292,439,000
234,888,000
207,736,000
133,742,000
148,303,000
130,900,000
121,500,000
18,100,000
14,700,000
3,300,000
-500,000
-12,400,000
-16,900,000
10,600,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.